These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 33571371)
1. Endosalpingiosis Is Negative for GATA3. White MJ; Vang R; Argani P; Cimino-Mathews A Arch Pathol Lab Med; 2021 Nov; 145(11):1448-1452. PubMed ID: 33571371 [TBL] [Abstract][Full Text] [Related]
2. Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma. Corben AD; Nehhozina T; Garg K; Vallejo CE; Brogi E Am J Surg Pathol; 2010 Aug; 34(8):1211-6. PubMed ID: 20631604 [TBL] [Abstract][Full Text] [Related]
3. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma. Djordjevic B; Malpica A Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998 [TBL] [Abstract][Full Text] [Related]
4. Benign müllerian glandular inclusions in men undergoing pelvic lymph node dissection. Gallan AJ; Antic T Hum Pathol; 2016 Nov; 57():136-139. PubMed ID: 27438608 [TBL] [Abstract][Full Text] [Related]
5. Two rare cases of endosalpingiosis in the axillary sentinel lymph nodes: evaluation of immunohistochemical staining and one-step nucleic acid amplification (OSNA) assay in patients with breast cancer. Shiino S; Yoshida M; Jimbo K; Asaga S; Takayama S; Maeshima A; Tsuda H; Kinoshita T; Hiraoka N Virchows Arch; 2019 May; 474(5):633-638. PubMed ID: 30756183 [TBL] [Abstract][Full Text] [Related]
6. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator. Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106 [TBL] [Abstract][Full Text] [Related]
7. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes. Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285 [TBL] [Abstract][Full Text] [Related]
8. Endosalpingiosis in axillary lymph nodes simulating metastatic breast carcinoma: a potential diagnostic pitfall. Salehi AH; Omeroglu G; Kanber Y; Omeroglu A Int J Surg Pathol; 2013 Dec; 21(6):610-2. PubMed ID: 24021901 [TBL] [Abstract][Full Text] [Related]
9. GATA3 immunohistochemistry expression in histologic subtypes of primary breast carcinoma and metastatic breast carcinoma cytology. Deftereos G; Sanguino Ramirez AM; Silverman JF; Krishnamurti U Am J Surg Pathol; 2015 Sep; 39(9):1282-9. PubMed ID: 26274030 [TBL] [Abstract][Full Text] [Related]
10. A subset of nondescript axillary lymph node inclusions have the immunophenotype of endosalpingiosis. Carney E; Cimino-Mathews A; Argani C; Kronz J; Vang R; Argani P Am J Surg Pathol; 2014 Dec; 38(12):1612-7. PubMed ID: 24921637 [TBL] [Abstract][Full Text] [Related]
11. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas. Cimino-Mathews A; Subhawong AP; Illei PB; Sharma R; Halushka MK; Vang R; Fetting JH; Park BH; Argani P Hum Pathol; 2013 Jul; 44(7):1341-9. PubMed ID: 23375642 [TBL] [Abstract][Full Text] [Related]
12. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Miettinen M; McCue PA; Sarlomo-Rikala M; Rys J; Czapiewski P; Wazny K; Langfort R; Waloszczyk P; Biernat W; Lasota J; Wang Z Am J Surg Pathol; 2014 Jan; 38(1):13-22. PubMed ID: 24145643 [TBL] [Abstract][Full Text] [Related]
13. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens. Shield PW; Papadimos DJ; Walsh MD Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220 [TBL] [Abstract][Full Text] [Related]
14. Wnt Family Member 9b (Wnt9b) Is a New Sensitive and Specific Marker for Breast Cancer. Lu S; Yakirevich E; Yang D; Xiao Y; Wang LJ; Wang Y Am J Surg Pathol; 2021 Dec; 45(12):1633-1640. PubMed ID: 34324458 [TBL] [Abstract][Full Text] [Related]
15. Utility of uroplakin II expression as a marker of urothelial carcinoma. Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628 [TBL] [Abstract][Full Text] [Related]
16. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation. Mohanty SK; Kim SA; DeLair DF; Bose S; Laury AR; Chopra S; Mertens RB; Dhall D Mod Pathol; 2016 Aug; 29(8):788-98. PubMed ID: 27125358 [TBL] [Abstract][Full Text] [Related]
18. Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis. Kim HS; Yoon G; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS; Song SY Int J Clin Exp Pathol; 2015; 8(5):5318-26. PubMed ID: 26191233 [TBL] [Abstract][Full Text] [Related]
19. Florid, papillary endosalpingiosis of the axillary lymph nodes. Stolnicu S; Preda O; Kinga S; Marian C; Nicolau R; Andrei S; Nicolae A; Nogales FF Breast J; 2011; 17(3):268-72. PubMed ID: 21477174 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Pargaonkar AS; Beissner RS; Snyder S; Speights VO Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]